Anzeige
Mehr »
Login
Mittwoch, 02.10.2024 Börsentäglich über 12.000 News von 692 internationalen Medien
Goldpreis steigt 2024 um 30 %, aber diese Aktie legt über 333 % zu – Hier ist der Grund
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
467 Leser
Artikel bewerten:
(2)

Valsoft Corp.: Valsoft Enter the IT Service and Asset Management Portfolio with the Acquisition of Professional Computing Resources

MONTREAL, QC / ACCESSWIRE / March 27, 2023 / Valsoft Corporation Inc. ("Valsoft"), a Montreal-based company specializing in the acquisition and development of software companies in vertical markets, is pleased to announce the acquisition of the assets of Professional Computing Resources ("PCR"), a leading developer of software solutions serving enterprise IT departments. This will mark entry into the IT Service and Asset Management (ITSM/ITAM) portfolio.

Valsoft Corp., Monday, March 27, 2023, Press release picture

With over 40 years of industry experience, PCR has built a reputation for providing organizations of all kinds and sizes with superior, affordable, and innovative software applications to help manage day-to-day IT service requests related to Moves, Adds, Changes and Deletes (MACDs); manage and track IT inventory; manage network resources, including cabling and network equipment, and manage and allocate IT expenditures. PCR is the market leader in the higher education space and has established a solid client base with the US federal and state governments and in the healthcare industry.

Commenting on the acquisition, Bob Glover, President of PCR, said "Valsoft identified PCR as a clear market leader with a robust reputation for providing exceptional customer service and product offering. Furthermore, throughout the discussions, Valsoft and PCR saw a great cultural fit between the two organizations we think will create an even better work environment. We are thrilled to be part of Valsoft."

This acquisition ensures that PCR's clients and partners will continue to receive the same high-quality solutions and support that they have come to expect from the existing management team of PCR.

"We are extremely pleased with the acquisition of PCR," said Valsoft CEO Sam Youssef. "PCR provides world-class technology solutions to some of the largest and most prestigious universities, as well as several state and federal government entities, and will be a great addition to the Valsoft family."

"We believe in the solid foundation and growth potential of PCR" said Michael Assi, CEO of Aspire Software, the operating arm at Valsoft. "PCRs solutions and service quality are second to none. Their products are easier to implement and maintain and have the most comprehensive functionality in this industry. We look forward to working with employees, clients, and partners to maintain its reputation, and take the business to the next level."

About Valsoft Corporation

Valsoft Corporation acquires and develops vertical market software companies through which each business can deliver the best mission-critical solutions for customers in their respective industries or niche. A key tenet of Valsoft's philosophy is to invest in well-established businesses and foster an entrepreneurial environment that shapes a company into a leader in its respective industry. Unlike private equity and VC firms, Valsoft does not have a predefined investment horizon and looks to buy, hold, and create value through long-term partnerships with existing management and customers.

About PCR

PCR is a leading developer of software applications for Enterprise IT departments. With over 40 years of industry experience, PCR provides solutions and services to help manage day-to-day IT service requests related to Moves, Adds, Changes and Deletes (MACDs); manage and track IT inventory; manage network resources, including cabling and network equipment, and manage and allocate IT expenditures.

Valsoft was represented internally by David Felicissimo, General Counsel and Shinjay (Ssin) Choi, Senior Legal Counsel. PCR was represented by FOCUS Investment Banking led by George Shea (Managing Director) and Rich Pierce (Managing Director).

For more information, visit https://www.pcr.com/ and https://valsoftcorp.com

Media contact information:
Joey Strizzi
Director of Communications and Public Relations
Valsoft Corporation
j.strizzi@valsoftcorp.com
Mobile: 514-258-0256

SOURCE: Valsoft Corp.

View source version on accesswire.com:
https://www.accesswire.com/745975/Valsoft-Enter-the-IT-Service-and-Asset-Management-Portfolio-with-the-Acquisition-of-Professional-Computing-Resources

© 2023 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.